PPT-Cautionary Language Concerning Forward-Looking Statements

Information set forth in this presentation contains financial estimates and other forwardlooking statements that are subject to risks and uncertainties and actual results might differ materially A discussion of factors that may affect future results is contained in ATampTs filings with the Securities and Exchange Commission ATampT disclaims any obligation to update and revise statements contained in this presentation based on new information or otherwise. Forward looking statements may include in particular statements about future events future financial performance plans strategies expectations prospects competitive environment regulation and supply and demand BASF has based these forward looking st Forward looking statements by their nature involve a number of risks and uncertainties that could cause actual results to differ materially from market expectations These risks and uncertainties include but are not limited to our ability to manage g Statements exceeding U.S. regulatory requirements which are difficult to verify through facility inspections (e.g., exclusion of vertebral columns from cattle 30 months of age or older or other age-re Some thoughts for the 2014 NZPF Annual Moot. Cathy Wylie. A Cautionary tale. . The mixed health of our primary and intermediate schools. Parents remain positive about the quality of their child’s schooling. Learn a language. Pass it on!. Virginia M. Scott. November 2013. Copyright . Virginia M. Scott 2013. All Rights Reserved. “Pay it forward”. “I do not pretend to give such a deed; I only lend it to you. When you [...] meet with another honest Man in similar Distress, you must pay me by lending this Sum to him; enjoining him to discharge the Debt by a like operation, when he shall be able, and shall meet with another opportunity. I hope it may thus go thro' many hands, before it meets with a Knave that will stop its Progress. This is a trick of mine for . This presentation contains “forward-looking information” within the meaning of Canadian Securities legislation. Generally, forward-looking statements can be identified by the use of forward-looking terminology such as “scheduled”, “anticipates”, “expects” or “does not expect”, “is expected”, “scheduled”, “targeted”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking statements contained herein include, without limitation, statements relating to mineral reserve estimates, mineral resource estimates, realization of mineral reserve and resource estimates, capital and operating costs estimates, the timing and amount of future production, costs of production, success of mining operations, the ranking of the project in terms of cash cost and production, permitting, economic return estimates, power and storage facilities, life of mine, social, community and environmental impacts, rare metal markets and sales prices, off-take agreements and purchasers for the Company’s products, environmental assessment and permitting, securing sufficient financing on acceptable terms, opportunities for short and long term optimization of the Project, and continued positive discussions and relationships with local communities and stakeholders. Forward-looking statements are based on assumptions management believes to be reasonable at the time such statements are made. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Although Matamec has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Factors that may cause actual results to differ materially from expected results described in forward-looking statements include, but are not limited to: . LOOKING INFORMATION. This presentation contains forward-looking statements and forward-looking information within the meaning of applicable securities laws, and are subject to risks and uncertainties that could cause actual results to differ. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by Cervus, including expectations and assumptions concerning the results of its due diligence review of the businesses proposed to be acquired by Cervus and the ability to the various approvals required. Additional detail about the material factors and/or assumptions employed to arrive at forward-looking information, as well as the material risk factors that may affect actual results, are contained in the MD&A section of our most recent quarterly filing which is available on the SEDAR website at www.sedar.com. Although Cervus believes that the expectations and assumptions on which such forward-looking statements and information are reasonable, undue reliance should not be placed on the forward looking statements and information as Cervus can give no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date hereof, and to not use such forward-looking information for anything other than its intended purpose. Cervus undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law. - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this overview that are not statements of historical fact are forwar Some thoughts for the 2014 NZPF Annual Moot. Cathy Wylie. A Cautionary tale. . The mixed health of our primary and intermediate schools. Parents remain positive about the quality of their child’s schooling. Thursday, September 8th. Warm-up…Word Study. Choose a word(s) from Unit 1.. Define the word.. List synonyms and antonyms.. Use the word in your own context sentence.. Draw an image that is related to the word and its context.. CORPORATE PRESENTATION. Pharmaceuticals. Q4 2017. This presentation contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein or which are otherwise made by or on behalf of the Company that are not statements of historical facts may be deemed forward‑looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “to,” “plan,” “expect,” “believe,” “anticipate,” “intend,” “could,” “should,” “would,” “estimate,” or “continue,” or the negative or other variations thereof or comparable terminology are intended to identify forward‑looking statements. Shareholders are cautioned that all forward‑looking statements involve risk and uncertainties which may cause results to differ materially from those set forth in the statements. Such risks and uncertainties include, but are not limited to the following: the success of research and development activities and the speed with which regulatory authorizations and product launches may be achieved; government regulation generally; competitive developments; the ability to successfully market products domestically and internationally; difficulties or delays in manufacturing or issues relating to manufacturing capacity; commercial obstacles to the successful introduction of brand products generally; legal defense costs, insurance expenses, settlement costs, and the risk of an adverse decision or settlement relating to product liability, patent protection, governmental investigations, and other legal proceedings; the Company’s ability to acquire and protect patents and other intellectual property both domestically and internationally; the absence of certainty regarding the receipt of required regulatory approval or the timing or terms of such approvals; any changes in business, political and economic conditions; business interruption due to hurricanes or other events outside of the Company’s control.. Certain statements in this presentation constitute “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Any statements that refer to expectations or other characterizations of future events, circumstances or results are forward-looking statements. Such forward-looking statements include projections. Such projections were not prepared in accordance with public guidelines of the American Institute of Certified Public Accountants regarding projections and forecasts, nor have such projections been audited, examined or otherwise reviewed by independent auditors of Wyndham Worldwide Corporation (“WYN”).. Dupuytren’s. Contracture; the expansion of the market for XIAFLEX for the treatment of . Peyronie’s. Disease and . Dupuytren’s. Contracture through future growth initiatives; the timing of Endo’s BLA submission and potential FDA approval in connection with and the potential commercial launch of XIAFLEX for the treatment of cellulite; whether treating uterine fibroids with XIAFLEX will achieve the advantages over major surgery identified by the Company and the timing of future clinical trials and the publication of results of clinical trials; Endo’s interest in currently unlicensed indications; whether XIAFLEX will be the only FDA approved nonsurgical therapy for adhesive capsulitis; the projected receipt of payments from Endo and sublicense income payments based on Endo’s partnerships; and the strength of the Company’s IP portfolio..